U.S. As the Food and Drug Administration (FDA) prepares to review two vaccine candidates for the crisis this month, U.S. The Centers for Disease Control and Prevention (CDC) Advisory Committee is set to vote on the COVID-19 vaccine priority position on Tuesday afternoon. Use authentication.
Vaccine administration priorities will be announced at a meeting on Tuesday, with health care workers and nursing home staff and residents expected to top the list. But some experts also say that vaccinating minority communities that have been disproportionately affected by the coronavirus should also be a priority.
It remains to be seen how the distribution will work locally and whether there will be sufficient doses to vaccinate health care workers and the elderly.
Emergency Physician at Naval Medical Center Portsmouth Dr. “Assumed (million crore) doses … are not enough to cover even these two groups,” Joshua Lesco wrote on Monday.
Dose Moderna (MRNA) and Pfizer (PFE) and Bioentech (BNTX) are expected to come from the pair, which has been filed for authorization for emergency use.
But the CDC on Tuesday focused on the first phase group, called Phase 1A, which, according to commentary from previous meetings, could only include health workers.
The need for vaccines for health workers has increased in recent weeks, as the country expects even more pressure on hospitals and health facilities after Thanksgiving. Despite a slight decrease in daily numbers due to strict thresholds for admission to hospitalized patients, the overall has increased. As of Tuesday, about 100,000 people had been hospitalized.
New administration
Experts are also focusing on the next administrative change, as most of the vaccine distribution will remain in office if President-elect Joe Biden.
It is understandable that Biden was involved in these decisions by the COVID-19 advisory board, but I suspect that a level of cooperation is being offered by the outgoing administration – which is unfortunate. Brigham and Women’s Hospital in Boston.
Meanwhile, as President Donald Trump faces the end of his administration, there is a question of what will happen to Operation Worm Speed and its top officials. But White House coronavirus adviser Dr. Scott Atlas, Resigned on Monday.
White House COVID-19 Task Force members are expected to be relieved by the resignation of a controversial adviser who was deemed unfit for the post by some. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, has repeatedly stated that he disagrees with Atlas and his views.
Most notably, Atlas advanced the idea of mob immunity, which allows Americans to get sick and avoid tricks to promote more natural immunity to the virus.
Dr. Ashish Jha, Dean, School of Public Health, Brown University Said on Twitter“A few people are (are) responsible for things going as badly as Scott. His tenure on federal parole (it) is really horrible. “
Zhao added that Atlas had spread misleading data and made many false claims about the virus, as he had “found a buyer” in Trump. Atlas, however, said they rely on data and have the support of experts from top organizations.
“I have always relied on the latest science and evidence … these views were in agreement with many of the world’s top epidemiologists and medical scientists,” Atlas said. “I can’t imagine a time where safeguarding science and scientific discussion is more urgent.”
More from Anjali:
Read the latest financial and business news from Yahoo Finance
Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, SmartNews, LinkedIn, YouTube.
